Notice of Intent To Grant an Exclusive License

AGENCY:

Department of Veterans Affairs, Office of Research and Development.

ACTION:

Notice of intent.

SUMMARY:

Notice is hereby given that the Department of Veterans Affairs, Office of Research and Development, intends to grant to Somahlution, Inc., 3401 Fiechtner Drive, Fargo, North Dakota 58103, USA, an exclusive license to practice the following: U.S. Patent No. 7,981,596 (Tissue preservation with a salt solution isotonic with interstitial fluid) issued July 19, 2011.

DATES:

Comments must be received March 16, 2012.

ADDRESSES:

Written comments may be submitted through www.regulations.gov;; by mail or hand-delivery to the Director, Regulations Management (02REG), Department of Veterans Affairs, 810 Vermont Avenue NW., Room 1068, Washington, DC 20420; or by fax to (202) 273-9026. Copies of comments received will be available for public inspection in the Office of Regulation Policy and Management, Room 1063B, between the hours of 8 a.m. and 4:30 p.m., Monday through Friday (except holidays). Call (202) 461-4902 for an appointment (This is not a toll-free number). In addition, during the comment period, comments may be viewed online through the Federal Docket Management System at http://www.regulations.gov .

FOR FURTHER INFORMATION CONTACT:

Amy E., Centanni, Director of Technology Transfer, Office of Research and Development (10P9TT), Department of Veterans Affairs, 810 Vermont Avenue NW., Washington, DC 20420, (202) 443-5640 (This is not a toll-free number). Copies of the published patent applications may be obtained from the U.S. Patent and Trademark Office at www.uspto.gov .

SUPPLEMENTARY INFORMATION:

It is in the public interest to so license these inventions, as Somahlution, Inc., submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within 15 days from the date of this published Notice, the Department of Veterans Affairs Office of Research and Development receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.